Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yaping Zhu

25PUBLICATIONS

99CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Apr 29, 2026

Efficacy and Safety of Pamiparib Monotherapy in Recurrent Ovarian Cancer After Prior PARPi Exposure: A Prospective, Open-Label, Single-Arm, Phase II Study.

|Nov 25, 2025

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial.

Lingying Wu, Jing Wang, Qingshui Li

|Oct 23, 2025

Personalized Cancer-Specific Protein-Aptamer Corona for Orthogonal Multiplex Cancer Diagnosis.

Jinlong Fan, Baichuan Jin, Xin Dai

|Aug 29, 2025

Optimal timing of primary debulking surgery in advanced ovarian cancer: insights from the TRUST trial.

Tingyan Shi, Yulian Chen, Rong Jiang

|Jul 23, 2025

Spatially resolved proteomics surveys the chemo-refractory proteins related to high-grade serous ovarian cancer.

Linyuan Fan, Yi Liu, Haichao Zhou

|Nov 25, 2024

Bimodal accurate H<sub>2</sub>O<sub>2</sub> regulation to equalize tumor-associated macrophage repolarization and immunogenic tumor cell death elicitation.

Yan Zhao, Weiheng Kong, Jianqing Zhu

Pageof 5

Frequent Collaborators

6 joint publications

Rutie Yin

5 joint publications

Rongyu Zang

5 joint publications

Ning Li

4 joint publications

Tingyan Shi

3 joint publications

Huixun Jia

3 joint publications

Jihong Liu

3 joint publications

Wei Zhang

3 joint publications

Xiaojun Chen

3 joint publications

Libing Xiang

2 joint publications

Huaying Wang

Frequent Collaborators

6 joint publications

Rutie Yin

5 joint publications

Rongyu Zang

5 joint publications

Ning Li

4 joint publications

Tingyan Shi

Top Related Videos

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays

Published on : Feb 24, 2023

Evaluating <em>In Vitro</em> DNA Damage Using Comet Assay

Evaluating <em>In Vitro</em> DNA Damage Using Comet Assay

Published on : Oct 11, 2017

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on : Sep 13, 2022

See more related videos

Top Related Videos

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids <em>via</em> Immunofluorescence Assays

Published on : Feb 24, 2023

Evaluating <em>In Vitro</em> DNA Damage Using Comet Assay

Evaluating <em>In Vitro</em> DNA Damage Using Comet Assay

Published on : Oct 11, 2017

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on : Sep 13, 2022

See more related videos